Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients

Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients

Abstract The composition of the gut microbiome of patients with advanced non-small cell lung cancer is currently considered a factor influencing the effectiveness of treatment with immune checkpoint inhibitors. We aimed to evaluate the baseline gut microbiome composition in patients before receiving...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Grenda, Ewelina Iwan, Barbara Kuźnar-Kamińska, Arkadiusz Bomba, Katarzyna Bielińska, Paweł Krawczyk, Izabela Chmielewska, Małgorzata Frąk, Michał Szczyrek, Anna Rolska-Kopińska, Tomasz Jankowski, Robert Kieszko, Janusz Milanowski
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Microbiome
NSCLC
Immunotherapy
16S rRNA
Immunotherapy efficacy
Online Access:https://doi.org/10.1038/s41598-025-89406-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items